Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-07-18 17:45 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ DE THERANEXUS CONCLU AVEC LA SOCIÉTÉ P…
|
French | 338.2 KB | ||
| 2022-07-12 18:00 |
Theranexus publie sa position de trésorerie au 30 juin 2022
|
French | 212.9 KB | ||
| 2022-07-12 18:00 |
Theranexus publishes its cash position as of 30 june 2022
|
English | 181.3 KB | ||
| 2022-06-09 18:00 |
THERANEXUS PARTICIPATES IN SEVERAL LEADING SCIENTIFIC CONFERENCES AND BUSINESS …
|
English | 253.3 KB | ||
| 2022-06-09 18:00 |
THERANEXUS PARTICIPERA À PLUSIEURS CONGRÈS SCIENTIFIQUES ET CONVENTIONS D'AFFAI…
|
French | 265.3 KB | ||
| 2022-06-07 18:00 |
ASSEMBLÉE GÉNÉRALE DU 22 JUIN 2022 : MISE À DISPOSITION DES DOCUMENTS PRÉPARATO…
|
French | 176.3 KB | ||
| 2022-05-25 18:00 |
Information mensuelle relative au nombre total de droits de vote et d'actions c…
|
French | 188.0 KB | ||
| 2022-04-29 18:25 |
Mise à disposition du document d'enregistrement universel 2021
|
French | 205.5 KB | ||
| 2022-04-29 16:39 |
URD 2021
|
French | 17.2 MB | ||
| 2022-04-25 09:20 |
Theranexus publishes its 2021 full-year results And announces a shift of its st…
|
English | 376.2 KB | ||
| 2022-04-25 09:15 |
Theranexus publie ses résultats annuels 2021 Et annonce son évolution stratégiq…
|
French | 372.6 KB | ||
| 2022-04-25 07:00 |
Theranexus publie ses résultats annuels 2021 et annonce son évolution stratégiq…
|
French | 372.4 KB | ||
| 2022-04-25 07:00 |
Theranexus publishes its 2021 full-year results And announces a shift of its st…
|
English | 375.9 KB | ||
| 2022-04-06 18:00 |
Information mensuelle relative au nombre total de droits de vote et d'actions c…
|
French | 272.3 KB | ||
| 2022-03-23 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 274.4 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
